Atropine sulfate
FDA Approved
Contents
Description
Atropine sulfate ophthalmic solution is an anticholinergic agent used for cycloplegia and mydriasis. It is commonly used in the management of refractive errors and amblyopia in pediatric patients with genetic refraction anomalies. The medication helps in diagnostic examination and therapeutic management of various congenital eye conditions.
Indications & Therapeutic Use
cycloplegia, mydriasis, amblyopia, refractive error management
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Atropine sulfate — GNH India
157 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Alcon
EU
ALCON ATROPINE
1 %solutionCANADA
Atorvastatina Cf
EU
Atrophine Sulfate Wockhardt Uk
EU
Atropin
EU
Atropin Abboxia
EU
Atropin Aguettant
EU
Atropin Bausch & Lomb
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Atropine sulfate
| Generic Name | atropine sulfate |
| Brands | 1 brand available |
| Active Ingredient | atropine sulfate |
| Drug Class | cycloplegia |
| Manufacturer | Alcon |
| Dosage Forms | ophthalmic solution 0.5%, 1% |
| Medical Code | S01FA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes